Speciality Medicines financial results announcements

Financial ResultsSpeciality Medicines Ltd 544738Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Speciality Medicines H2 FY26 Results: Net Profit ₹8.2 Cr, Up 203.7% YoY

Speciality Medicines Ltd reported revenue from operations of ₹44.8 Cr (+45.5% YoY) and net profit of ₹8.2 Cr (+203.7% YoY) for H2 FY26.

Key figure

Net profit ₹8.2 Cr · +203.7% YoY

Financial ResultsSpeciality Medicines Ltd 544738

Speciality Medicines Financial Results

Speciality Medicines Ltd reported its audited standalone financial results for the year ended March 31, 2026. The company also confirmed full utilization of its IPO proceeds.